Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Laryngoscopes Market Size & Share 2026-2035
Report ID: GMI5269
|
Published Date: September 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Download Free PDF
Laryngoscopes Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Laryngoscopes Market Size
The laryngoscopes market was valued at USD 590 million in 2025, projected to reach USD 635 million in 2026, advancing at a 7.5% CAGR (2026–2035), and forecast to reach USD 1.22 billion by 2035. The market covers devices and integral accessories used to visualize the larynx and glottis during intubation, including video and fiber optic systems in reusable and disposable formats.
Laryngoscopes Market Key Takeaways
Market Leader: Medtronic led with over 19.5% market share in 2025.
Leading Players: Top 5 players in this market include Medtronic, STORZ, Ambu, RICHARD WOLF, INTERSURGICAL, which collectively held a market share of 45.6% in 2025.
The market is moving from a predominantly instrument-led purchase toward a clinical-workflow decision. Higher-acuity procedures, standardization of airway protocols, and the recurring economics of blades are increasing the value of visualization and availability, while procurement remains sensitive to capital budgets, reprocessing capability, and clinician familiarity with direct technique.
GMI Analyst View
Based on our primary research and revenue-disclosure analysis across device suppliers and healthcare procurement channels, the top five manufacturers accounted for approximately 45.6% of global market revenue in 2025. We view this as a moderately fragmented structure: established platforms have meaningful installed-base advantages, but specialist and regional suppliers retain room to win accounts where product fit, service coverage, or procurement economics are decisive.
Laryngoscopes Market Trends, Growth Drivers & GMI Forecast Outlook
The forecast reflects a durable shift toward visualized, lower-reprocessing-burden airway management rather than a uniform replacement of conventional tools. Clinical evidence and sterile-services pressures strengthen adoption in high-acuity settings, while affordability, workflow readiness, and direct-laryngoscopy familiarity keep conversion uneven across care settings and geographies.
Key Drivers
*Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.*
Obesity changes airway management demand through anatomy, not merely procedure volume. Restricted mouth opening, cervical tissue distribution, and reduced margin for rescue can increase the value of first-pass visualization; published evidence also associates patient and surgery characteristics with difficult or failed intubation risk [3]Nørskov AK, Rosenstock CV, Wetterslev J, et al. “Patient and Surgery Factors Associated with the Incidence of Failed and Difficult Intubation.” doi.org. For providers, that makes advanced platforms most compelling where case mix and adverse-event exposure are concentrated.
The video-laryngoscopy signal matters because it can move purchasing from clinician preference to protocol design. When anesthesia, critical care, and emergency departments align on standardized difficult-airway pathways, hospitals can justify common monitors, training, and blade inventories. The commercial benefit extends beyond initial capital placement to a more predictable replenishment relationship.
Reprocessing compliance creates a separate demand pathway. Facilities with limited sterile-services capacity must weigh validated cleaning, handling, and documentation against the simplicity of a ready-to-use device. Disposable adoption therefore can advance even where clinicians do not perceive a large performance difference, particularly in time-sensitive operating room and ICU workflows.
Key Restraints
*Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.*
Capital scarcity is most consequential where procedure volumes are rising but public procurement remains tightly governed. Manufacturers serving these systems must make decisions on price architecture, certification, distributor support, and serviceability that differ from premium platform strategies. The result is a bifurcated demand pattern between well-funded private accounts and cost-led public tenders.
Conversion inertia is also operational. A clinician with dependable direct-laryngoscopy performance in routine cases may not see sufficient benefit to alter technique, workflow, or equipment preparation. This keeps video adoption concentrated first in high-risk and high-acuity pathways rather than immediately displacing conventional devices across the entire procedural base.
Training and device-readiness constraints preserve the role of simpler configurations in pre-hospital, emergency, and low-resource environments. Their continued relevance limits the addressable market for monitor-dependent systems and favors suppliers able to offer durable, quickly deployable alternatives.
GMI Analyst View
We see the central forecast question as the pace of conversion, not the clinical relevance of visualization. Institutions with established procurement governance and infection-prevention infrastructure can turn evidence into standardized use more quickly; cost-sensitive systems will adopt selectively. That divergence should concentrate premiumization in particular account types rather than distribute it evenly across global demand.
Laryngoscopes Market Segment Analysis
By Type
The video laryngoscope segment generated USD 307 million in 2025, representing 52.0% of global revenue, and is projected to expand at a 10.5% CAGR (2026–2035). The Laryngoscopes Market is rewarding video platforms where first-attempt success, documentation, and standardized airway pathways carry high operational value. Their advantage is strongest in high-acuity hospital settings, where a common platform can support protocol adherence while recurring blade demand improves supplier account depth.
Fiber optic laryngoscopes are projected to reach USD 393 million by 2035 and grow at a 3.3% CAGR (2026–2035). Fiber optic systems retain an important role in anticipated difficult-airway cases that require navigability around anatomical restrictions. Their slower trajectory reflects the expanding capability of video-enabled alternatives, but flexible visualization and specialized approach angles preserve a meaningful clinical niche.
By Device Type
Rigid laryngoscopes held a 58.0% market share in 2025 and are forecast to reach USD 687 million by 2035. Familiar blade geometry, rapid deployment, and compatibility with standard workflows sustain rigid systems in operating rooms and emergency settings. Video integration allows suppliers to add visualization without requiring clinicians to abandon established insertion mechanics, protecting the category's relevance as procedural expectations change.
Flexible laryngoscopes are forecast to reach USD 540 million by 2035 and expand at an 8.1% CAGR (2026–2035). Flexible platforms address cases in which limited neck extension, reduced mouth opening, or obstructive pathology makes a rigid approach less suitable. More systematic airway assessment should favor planned use of these systems in difficult-airway pathways rather than reserving them solely for rescue situations.
By Usability
Reusable laryngoscopes accounted for 54.0% of global revenue in 2025 and are projected to grow at a 4.9% CAGR (2026–2035). Reuse remains economically persuasive for institutions with established sterile-services infrastructure and constrained device budgets. Nevertheless, its relative position is pressured where the full cost of reprocessing, documentation, and storage is increasingly considered alongside acquisition price.
Disposable laryngoscopes are positioned to capture 58.0% of global revenue by 2035 and grow at a 10.1% CAGR (2026–2035). Single-use products combine workflow simplicity with a clearer infection-control proposition. The category is particularly well aligned with hospitals and outpatient facilities seeking predictable availability, reduced reprocessing exposure, and a consumable model that can scale with procedure throughput.
By End Use
Hospitals generated USD 336 million in 2025 and are projected to retain a 52.0% share of global revenue by 2035. Hospitals remain the core channel because operating rooms, ICUs, and emergency departments combine high procedure volumes with the greatest demand for advanced airway-management capability. Academic and tertiary facilities also influence protocol formation and platform selection across wider health-system networks.
Ambulatory surgical centers are forecast to reach USD 405 million by 2035 and expand at a 9.4% CAGR (2026–2035). ASCs offer a favorable setting for single-use laryngoscopes: throughput discipline and the absence of hospital-scale reprocessing infrastructure make ready-to-use configurations operationally attractive. Their growth broadens the purchasing base beyond inpatient hospital accounts.
Other end-use settings accounted for 15.0% of global revenue in 2025 and are projected to generate USD 184 million by 2035. Emergency medical services, defense health, urgent care, and training environments require products that fit varied readiness and durability needs. Collectively, these settings maintain a broad demand base for conventional configurations even as advanced systems gain share in controlled clinical environments.
GMI Analyst View
We interpret the segmentation pattern as a migration toward configurations that pair clinical performance with lower process burden. The most attractive opportunities arise where visualization, infection prevention, and repeat purchasing reinforce one another. Yet the persistence of specialized difficult-airway needs and resource-constrained use cases means that this will remain a portfolio market, not a single-technology market.
Laryngoscopes Market Regional Analysis
North America Laryngoscopes Market Analysis
North America generated USD 224 million in 2025 and is forecast to reach USD 428 million by 2035. The Laryngoscopes Market in North America benefits from mature hospital infrastructure, sizable surgical throughput, and procurement systems that can support advanced device adoption. Group purchasing, quality scrutiny, and established clinical evidence pathways make the region a critical reference market for premium video and single-use systems.
U.S.
The U.S. generated USD 189 million in 2025, representing 32.0% of global revenue, and is forecast to reach USD 352 million by 2035. High procedure volumes across academic centers, community networks, and ASCs underpin U.S. demand. Device-safety oversight and a large evidence-generation base also raise procurement scrutiny, creating both quality expectations and replacement opportunities as installed platforms evolve.
Europe Laryngoscopes Market Analysis
Europe is forecast to reach USD 267 million by 2035 and grow at a 7.0% CAGR (2026–2035). The region's national tender systems and healthcare-budget frameworks create varied adoption rates, but infection prevention and sterile-services requirements favor single-use products in major hospital systems. Germany and the United Kingdom remain influential reference markets for airway-management protocols and purchasing standards.
Germany
Germany generated USD 32 million in 2025 and is projected to reach USD 64 million by 2035. University hospitals and larger academic centers shape technology adoption in a procurement environment that places high weight on evidence and hygiene standards. Domestic endoscopy expertise also gives providers close access to advanced platform development and specialist support.
United Kingdom
The United Kingdom is forecast to reach USD 55 million by 2035 and grow at a 7.0% CAGR (2026–2035). Centralized NHS procurement and national airway-management guidance make clinical consensus particularly consequential for adoption. Default videolaryngoscopy pathways and efforts to simplify decontamination can shift demand from discretionary equipment choices toward standardized system-wide purchasing.
Asia Pacific Laryngoscopes Market Analysis
Asia Pacific is forecast to reach USD 395 million by 2035, representing 32.2% of global revenue, and grow at a 9.1% CAGR (2026–2035). Asia Pacific combines hospital-capacity expansion with increasing clinical sophistication, creating a larger procedure base alongside an upgrade cycle. The balance between private-hospital premiumization and public-sector affordability will determine how much of that growth converts to advanced video and disposable configurations.
China
China generated USD 55 million in 2025 and is forecast to grow at a 9.7% CAGR (2026–2035). A two-track market is emerging, with international brands concentrated in higher-tier institutions and domestic suppliers addressing mid-market accounts. Hospital expansion, insurance coverage, and the needs of an aging patient population support the underlying case for modern airway visualization.
Japan
Japan generated USD 38 million in 2025 and is forecast to reach USD 76 million by 2035. Universal coverage, sophisticated hospital infrastructure, and demanding quality expectations favor premium systems. An older patient mix also increases the relevance of platforms designed to manage anatomical restrictions and more complex perioperative airway decisions.
India
India is forecast to reach USD 80 million by 2035 and expand at an 11.1% CAGR (2026–2035). Private-hospital construction, rising surgical activity, and accredited-facility infection-control practices are widening access to advanced airway equipment. FDI in hospitals and diagnostics reached USD 1.56 billion in FY2025, supporting the infrastructure context for this expansion [4]Rubix Data Sciences and Pharmabiz. “FDI in Hospitals and Diagnostics Hits USD 1.56 Billion in FY2025, Up 2.3x Since FY2022.” pharmabiz.com. Cost-appropriate portfolios and capable distribution will be important beyond the largest metropolitan accounts.
South Korea
South Korea generated USD 17 million in 2025 and is forecast to grow at an 8.4% CAGR (2026–2035). High hospital density and a technically advanced clinical workforce support early adoption of premium systems. Academic medical centers and domestic device capabilities provide influential reference sites, while regulation aligned with international quality expectations supports established suppliers.
Latin America Laryngoscopes Market Analysis
Latin America generated USD 35 million in 2025 and is forecast to grow at a 7.0% CAGR (2026–2035). Private hospital networks are the principal channel for advanced platforms, whereas public procurement remains price-led. This split rewards suppliers that can sustain distributor coverage and position differentiated products without losing relevance in conventional-device tenders.
Brazil
Brazil generated USD 16 million in 2025 and is projected to reach USD 32 million by 2035. Brazil's public-private divide shapes both purchasing power and product mix. Private tertiary centers are likely to lead adoption of advanced and single-use configurations, while broader public demand continues to emphasize affordability and reliable supply.
Middle East & Africa Laryngoscopes Market Analysis
Middle East & Africa generated USD 30 million in 2025, representing 5.1% of global revenue, and is forecast to grow at an 8.5% CAGR (2026–2035). Gulf healthcare investment supports modern hospital construction, technology procurement, and clinical training, while many African markets remain earlier in their adoption curve. The region therefore combines near-term premium opportunities in the Gulf with longer-term infrastructure-led demand elsewhere.
Saudi Arabia
Saudi Arabia is forecast to generate USD 24 million by 2035 and grow at a 9.2% CAGR (2026–2035). Healthcare transformation investment is strengthening the institutional capacity for advanced airway-management procurement. Newly commissioned facilities and wider adoption of internationally recognized infection-control practices favor single-use configurations, although local service and training remain essential to sustained uptake.
GMI Analyst View
We see two different regional growth models. Mature markets derive value primarily from technology refreshes and workflow conversion, whereas high-growth regions add procedure capacity while upgrading equipment. Manufacturers that can protect premium positioning in developed accounts while offering credible value architectures in expanding health systems will be better placed to capture both dynamics.
Laryngoscopes Market Share & Competitive Landscape
The Laryngoscopes Market share structure is moderately fragmented, with multinational suppliers competing against regional and specialty manufacturers on visualization quality, platform breadth, consumable economics, and distribution reach. Competitive advantage increasingly depends on the ability to integrate capital devices, blades, training, and service into a credible clinical-workflow proposition.
Medtronic held a 19.5% revenue share in 2025. Its McGRATH MAC franchise gives the company a substantial installed-base position in video laryngoscopy. Device-generation management and the ability to support account transitions are strategically important because replacement decisions can affect both platform loyalty and future blade purchasing.
STORZ held an 11.9% market share in 2025. The C-MAC platform's blade range and imaging reputation support its standing in hospital accounts that value versatility and evidence-backed workflow fit. STORZ's competitive position rests on maintaining a differentiated clinical proposition as single-use alternatives become more central to procurement decisions.
Ambu held a 7.6% share in 2025. Ambu is using a single-use, integrated airway-management approach to challenge reusable-platform incumbents. Shared visualization infrastructure across laryngoscopy and bronchoscopy can lower equipment duplication for accounts, while its disposable orientation aligns the company directly with infection-control-driven purchasing.
RICHARD WOLF maintains a specialized position centered on optical engineering and durable rigid and fiber optic systems, particularly in European specialty care. INTERSURGICAL competes through its i-View platform and broader respiratory-care range, where its single-use orientation is well aligned with changing airway-management workflows. Baxter, FUJIFILM, Olympus Corporation, BESDATA, and Teleflex add competitive pressure through anesthesia, imaging, regional-value, and single-use portfolios. The market consequently favors suppliers that can combine product reliability, procurement accessibility, and clinical training rather than compete on device specifications alone.
Recent Industry Developments
Ambu receives CE Mark for the full SureSight video laryngoscope portfolio in Europe (April 2026). Ambu announced CE Mark certification for its complete SureSight portfolio, covering integrated and standalone configurations, to enable a European rollout across hospital, ICU, and emergency-care settings [6]Ambu A/S. “Ambu Receives CE Mark for Full SureSight Video Laryngoscope Portfolio in Europe.” ambu.com. The clearance expands Ambu's ability to compete for accounts transitioning from established reusable video-laryngoscope platforms.
Ambu introduced SureSight Mobile for emergent and unplanned intubation settings (December 2025). The handheld system incorporates an integrated screen, extending the platform into settings where an external monitor is not practical [5]Ambu A/S. “Introducing Ambu® SureSight™ Mobile Video Laryngoscope.” ambu.com. Its controlled release with selected hospitals illustrates the importance of standalone workflow design in emergency-use positioning.
Intersurgical initiated a Class I recall of specified i-View video laryngoscope lots (June 2025). The FDA classified the action as a Class I recall following reports involving battery depletion, leakage, and screen blank-out [7]U.S. Food and Drug Administration. “Recall Alert: Intersurgical Inc Removes i-View Video Laryngoscope.” fda.gov. The event underscores how component reliability and post-market quality systems can influence hospital confidence in an increasingly technology-dependent category.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →